Last updated: November 14, 2026
To market a biotech startup, start with a clear scientific and commercial narrative, build credibility with investors and partners before patients, publish and present your data at the right congresses, invest in a professional website and investor materials, use targeted PR around financings and data readouts, and add digital demand programs only when you have a product or service to sell.
Biotech marketing is different from most startup marketing. Your first audiences are investors, pharma partners, key opinion leaders and talent, and promotional claims about unapproved therapies are restricted. This guide is part of our Tech & Life Sciences Marketing hub.
Write one page that explains the problem, your science, why it is different and what milestones are ahead. Every deck, website page and press release should follow it. Specialist branding agencies like those on our biotech branding list can help sharpen it.
| Audience | What They Need | Main Channels |
|---|---|---|
| Investors | Science, team, data, path to value | Decks, IR events, financial and trade press |
| Pharma partners | Differentiated data and platform fit | BD meetings, partnering conferences, publications |
| Key opinion leaders | Rigorous science and clinical relevance | Congresses, advisory boards, publications |
| Talent | Mission, culture and momentum | Website careers pages, LinkedIn, media coverage |
| Patients and advocates | Disease education and trial information | Advocacy groups, trial recruitment campaigns |
Peer-reviewed publications, posters and congress talks are the most credible marketing a biotech has. Plan publications early and coordinate them with corporate milestones.
Financings, first-in-human dosing, data readouts and partnerships are the moments when trade press like STAT, Endpoints and Fierce Biotech pay attention. A specialist biotech PR firm helps you prepare announcements and spokespeople.
Your website is where investors, partners and candidates check you out. Keep the pipeline, team, publications and news current, and make sure it reads clearly to non-specialists.
Do not promote unapproved uses or make efficacy claims for investigational products. Describe programs factually, follow disclosure rules if you are public, and route materials through medical and legal review.
Tools, services and platform biotechs can run SEO, content and paid campaigns aimed at scientists and procurement teams. Therapeutics companies usually wait until closer to launch.
From day one in a limited form: a clear narrative, a professional website and investor materials. Broader marketing grows as data and milestones arrive.
Early-stage biotechs often spend modestly on branding, website and PR, commonly tens of thousands to low hundreds of thousands of dollars a year, rising sharply before commercial launch.
No. Companies can discuss science and clinical trials factually, but cannot promote an investigational product as safe or effective for unapproved uses.
Many start with specialist agencies for branding, PR and web, then hire in-house communications leaders as they grow.
Successful biotech marketing starts with a clear narrative, builds credibility through science and milestones, and adds demand programs only when there is something to sell.
Find partners in our lists of life sciences and biotech marketing agencies, biotech PR firms and biotech branding agencies.